Literature DB >> 3181382

HBV, HDV and HIV infections in 242 drug addicts: two-year follow-up.

C Mandelli1, M Cesana, P Ferroni, G P Lorini, G P Aimo, A Tagger, P A Bianchi, D Conte.   

Abstract

Of 242 north Italian heroin addicts, 24 (9.9%) were HBsAg positive. HBeAg was positive in two of them (8.3%), anti-HBe in 16 (66.6%) and anti-HDV in 21 (87.5%). Of the 218 HBsAg negative, 182 (83.5%) had anti-HBc, 72 (33.0%) anti-HBe and 97 (44.5%) anti-HBs. One-hundred-eighty-five drug addicts were anti-HIV positive (76.4%); 77 of these (41.6%) were asymptomatic, 93 (50.3%) had PGL and 15 (8.1%) ARC. T4+ cell count was significantly lower in subjects with ARC as was T4+/T8+ ratio in subjects with PGL and ARC. During a median follow-up of 9.5 months (range 4-25), we observed three new cases of hepatitis (two caused by NANBV and one by HBV with HDV coinfection) and one new HIV infection. Ten anti-HIV positive subjects developed PGL and one AIDS.

Entities:  

Mesh:

Year:  1988        PMID: 3181382     DOI: 10.1007/bf00148917

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

Authors:  B F Polk; R Fox; R Brookmeyer; S Kanchanaraksa; R Kaslow; B Visscher; C Rinaldo; J Phair
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

2.  The Walter Reed staging classification for HTLV-III/LAV infection.

Authors:  R R Redfield; D C Wright; E C Tramont
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

Review 3.  [Delta hepatitis virus: 3rd identified hepatitis virus].

Authors:  C Trépo; M Rizzetto
Journal:  Gastroenterol Clin Biol       Date:  1986-03

4.  Rapid spread of HTLV-III infection among drug addicts in Italy.

Authors:  G Angarano; G Pastore; L Monno; T Santantonio; N Luchena; O Schiraldi
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.

Authors:  E A Follett; A McIntyre; B O'Donnell; G B Clements; U Desselberger
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members.

Authors:  J J Goedert; R J Biggar; S H Weiss; M E Eyster; M Melbye; S Wilson; H M Ginzburg; R J Grossman; R A DiGioia; W C Sanchez
Journal:  Science       Date:  1986-02-28       Impact factor: 47.728

7.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

8.  Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome.

Authors:  U Mathur-Wagh; R W Enlow; I Spigland; R J Winchester; H S Sacks; E Rorat; S R Yancovitz; M J Klein; D C William; D Mildvan
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

9.  Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.

Authors:  A R Zanetti; P Ferroni; M Colombo; A Cargnel; D Mari; G Zehender; M G Rumi; A Gringeri; M Ammassari; P M Mannucci
Journal:  Ric Clin Lab       Date:  1985 Oct-Dec

10.  The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers.

Authors:  K Krogsgaard; B O Lindhardt; J O Nielson; P Andersson; P Kryger; J Aldershvile; J Gerstoft; C Pedersen
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

View more
  2 in total

1.  HIV serology among Italian male military recruits at entrance and discharge.

Authors:  A Carducci; M Giorgi; G Benedettini; C M Avio; M Bendinelli
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

Review 2.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.